Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
Status:
Completed
Trial end date:
2013-05-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability and efficacy of the
topical application of AP611074 5% gel during 6 weeks on ano-genital warts caused by human
papillomavirus (HPV).